MERONI, MARINA
 Distribuzione geografica
Continente #
AS - Asia 1.442
NA - Nord America 791
EU - Europa 580
SA - Sud America 218
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.059
Nazione #
US - Stati Uniti d'America 757
SG - Singapore 451
CN - Cina 291
VN - Vietnam 257
IT - Italia 215
HK - Hong Kong 158
RU - Federazione Russa 152
BR - Brasile 150
KR - Corea 53
BD - Bangladesh 50
DE - Germania 48
IN - India 47
ID - Indonesia 29
NL - Olanda 28
GB - Regno Unito 25
FR - Francia 24
AR - Argentina 23
IQ - Iraq 21
CO - Colombia 16
CA - Canada 15
FI - Finlandia 15
AT - Austria 12
ES - Italia 12
EC - Ecuador 11
MX - Messico 10
PH - Filippine 10
SA - Arabia Saudita 10
SE - Svezia 10
TR - Turchia 10
ZA - Sudafrica 10
JP - Giappone 9
PK - Pakistan 8
PL - Polonia 8
UA - Ucraina 8
IE - Irlanda 6
JO - Giordania 6
MA - Marocco 6
CH - Svizzera 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
MY - Malesia 4
VE - Venezuela 4
CL - Cile 3
PE - Perù 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
BE - Belgio 2
BO - Bolivia 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NI - Nicaragua 2
PT - Portogallo 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 3.059
Città #
Singapore 292
Hong Kong 157
San Jose 157
Hefei 103
Hanoi 94
Milan 86
Ho Chi Minh City 70
Ashburn 66
Seoul 53
Beijing 48
Santa Clara 42
Burlingame 28
Chicago 28
Los Angeles 23
Moscow 23
Rome 23
Jakarta 20
Munich 19
New York 17
The Dalles 17
Buffalo 16
Council Bluffs 16
Shanghai 16
São Paulo 15
Dallas 14
Hyderabad 14
Lauterbourg 13
Haiphong 12
Baghdad 10
Chennai 10
Orem 10
Da Nang 9
Amsterdam 8
Tokyo 8
Boardman 7
Chandler 7
Guangzhou 7
Helsinki 7
Quito 7
Amman 6
Dhaka 6
Dublin 6
Frankfurt am Main 6
Kochi 6
Nuremberg 6
Poplar 6
Warsaw 6
Washington 6
Bari 5
Biên Hòa 5
Boston 5
Figino 5
Istanbul 5
Montreal 5
Mumbai 5
Redwood City 5
Rio de Janeiro 5
Vienna 5
Arezzo 4
Barcelona 4
Brasília 4
Brooklyn 4
Charlotte 4
Kent 4
Mountain View 4
Newark 4
Porto Alegre 4
Reggio Emilia 4
Salt Lake City 4
Tashkent 4
Thái Nguyên 4
Turin 4
Baku 3
Belo Horizonte 3
Bitonto 3
Bogotá 3
Bắc Ninh 3
Can Tho 3
Caxias do Sul 3
Dammam 3
Ha Long 3
Hamburg 3
Jeddah 3
Johannesburg 3
Lappeenranta 3
Lima 3
London 3
Manaus 3
Mauá 3
Mexico City 3
Montevideo 3
Naples 3
Philadelphia 3
Phoenix 3
Quận Bình Thạnh 3
Seattle 3
Stockton 3
Sulaymaniyah 3
Toronto 3
Turku 3
Totale 1.816
Nome #
Induction of adipocytic differentiation in myxoid liposarcoma: new approaches to improve the effectiveness of the available therapies 335
MSIpixel: a fully automated pipeline for compound annotation and quantitation in mass spectrometry imaging experiments 231
Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imaging 174
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models 162
Establishment and characterization of a new panel of uterine leiomyosarcoma patient-derived xenograft models 159
Mechanism of efficacy of trabectedin against myxoid liposarcoma entails detachment of the FUS-DDIT3 transcription factor from its DNA binding sites 157
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy 151
Abstract 7199: The retinoid X receptor (RXR) agonist IRX4204 potentiates the efficacy of trabectedin and pioglitazone in myxoid liposarcoma preclinical models 150
Pharmacokinetic evaluation of trabectedin and pioglitazone combination in myxoid liposarcoma patient-derived xenografts. 144
Pharmacokinetics of the combination of trabectedin and pioglitazone in myxoid liposarcoma patient-derived xenograft models 144
Induction of adipocytic differentiation in myxoid liposarcoma: new approaches to improve the effectiveness of the available therapies 142
The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma 142
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma 139
Betulinic acid and its spray dried microparticle formulation: In vitro PDT effect against ovarian carcinoma cell line and in vivo plasma and tumor disposition 138
Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging 136
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells 135
Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli‐Responsive Nanocages 127
Corrigendum to “Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma” [Genomics Volume 113, Issue 5, September 2021, Pages 3439–3448] (Genomics (2021) 113(5) (3439–3448), (S0888754321003062), (10.1016/j.ygeno.2021.07.028)) 121
The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma. 121
Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice 114
Totale 3.122
Categoria #
all - tutte 10.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202317 1 1 1 3 2 4 0 3 2 0 0 0
2023/2024123 0 1 0 7 4 5 33 12 12 2 6 41
2024/20251.084 38 94 54 33 46 48 50 55 120 125 105 316
2025/20261.895 213 174 174 230 215 65 183 91 181 119 82 168
2026/20273 3 0 0 0 0 0 0 0 0 0 0 0
Totale 3.122